• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Preoperative High Level of Circulating Tumor Cells is an Independent Risk Factor for Central Lymph Node Metastasis in Papillary Thyroid Carcinoma with Maximum Lesion Diameter ≤1.0 cm.术前循环肿瘤细胞高水平是最大病灶直径≤1.0 cm的乳头状甲状腺癌中央淋巴结转移的独立危险因素。
Int J Gen Med. 2024 Oct 25;17:4907-4916. doi: 10.2147/IJGM.S487992. eCollection 2024.
2
Risk factors analysis of lateral cervical lymph node metastasis in papillary thyroid carcinoma: a retrospective study of 830 patients.甲状腺乳头状癌侧颈部淋巴结转移的危险因素分析:一项 830 例患者的回顾性研究。
World J Surg Oncol. 2024 Jun 21;22(1):162. doi: 10.1186/s12957-024-03455-w.
3
The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.桥本甲状腺炎共存对甲状腺乳头状癌中央区淋巴结转移的影响。
Front Endocrinol (Lausanne). 2021 Nov 16;12:772071. doi: 10.3389/fendo.2021.772071. eCollection 2021.
4
Integrating US-guided FNAB, BRAF mutation, and clinicopathologic characteristics to predict cervical central lymph-node metastasis in preoperative patients with cN0 papillary thyroid carcinoma.将 US 引导下的细针穿刺活检、BRAF 突变与临床病理特征相结合,预测术前 cN0 甲状腺乳头状癌患者颈中央区淋巴结转移。
Eur Arch Otorhinolaryngol. 2023 Dec;280(12):5565-5574. doi: 10.1007/s00405-023-08156-w. Epub 2023 Aug 4.
5
Clinical features of multifocal papillary thyroid carcinoma and risk factors of cervical metastatic lymph nodes.多灶性甲状腺乳头状癌的临床特征及颈淋巴结转移的危险因素。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Apr 25;51(2):225-232. doi: 10.3724/zdxbyxb-2021-0389.
6
Analysis of the Relevance of the Ultrasonographic Features of Papillary Thyroid Carcinoma and Cervical Lymph Node Metastasis on Conventional and Contrast-Enhanced Ultrasonography.甲状腺乳头状癌超声特征与颈部淋巴结转移在常规超声及超声造影上的相关性分析
Front Oncol. 2021 Dec 23;11:794399. doi: 10.3389/fonc.2021.794399. eCollection 2021.
7
A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.甲状腺乳头状癌的回顾性研究:桥本甲状腺炎作为淋巴结转移的保护性生物标志物
Eur J Surg Oncol. 2023 Mar;49(3):560-567. doi: 10.1016/j.ejso.2022.11.014. Epub 2022 Nov 11.
8
A comprehensive prediction model for central lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis: BRAF may not be a valuable predictor.桥本甲状腺炎合并甲状腺乳头状癌中央区淋巴结转移的综合预测模型:BRAF 可能不是一个有价值的预测指标。
Front Endocrinol (Lausanne). 2024 Sep 19;15:1429382. doi: 10.3389/fendo.2024.1429382. eCollection 2024.
9
Hashimoto's Thyroiditis Is Associated With Central Lymph Node Metastasis in Classical Papillary Thyroid Cancer: Analysis from a High-Volume Single-Center Experience.桥本甲状腺炎与经典型甲状腺乳头状癌中央区淋巴结转移相关:来自大容量单中心经验的分析。
Front Endocrinol (Lausanne). 2022 May 20;13:868606. doi: 10.3389/fendo.2022.868606. eCollection 2022.
10
The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study.桥本甲状腺炎对单灶及多灶性乳头状甲状腺癌淋巴结转移的影响:一项中国回顾性队列研究
Medicine (Baltimore). 2016 Feb;95(6):e2674. doi: 10.1097/MD.0000000000002674.

引用本文的文献

1
Positive preoperative circulating tumor cells level associated with lymph node metastasis in papillary thyroid carcinoma patients with capsular invasion.术前循环肿瘤细胞水平呈阳性与有包膜侵犯的乳头状甲状腺癌患者的淋巴结转移相关。
World J Surg Oncol. 2025 May 14;23(1):190. doi: 10.1186/s12957-025-03842-x.
2
Preoperative circulating tumor cells level is associated with lymph node metastasis in patients with unifocal papillary thyroid carcinoma.术前循环肿瘤细胞水平与单灶性乳头状甲状腺癌患者的淋巴结转移相关。
World J Surg Oncol. 2025 Feb 11;23(1):47. doi: 10.1186/s12957-025-03702-8.
3
Pretreatment level of circulating tumor cells is associated with lymph node metastasis in papillary thyroid carcinoma patients with ≤ 55 years old.55岁及以下乳头状甲状腺癌患者的循环肿瘤细胞预处理水平与淋巴结转移相关。
World J Surg Oncol. 2025 Jan 29;23(1):29. doi: 10.1186/s12957-025-03670-z.

本文引用的文献

1
Diagnostic value of circulating tumor cells in patients with thyroid cancer: a retrospective study of 1478 patients.循环肿瘤细胞在甲状腺癌患者中的诊断价值:一项对1478例患者的回顾性研究
Discov Oncol. 2024 Apr 12;15(1):114. doi: 10.1007/s12672-024-00976-4.
2
Spatial transcriptomics reveals prognosis-associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment.空间转录组学揭示了甲状腺乳头状癌微环境中与预后相关的细胞异质性。
Clin Transl Med. 2024 Mar;14(3):e1594. doi: 10.1002/ctm2.1594.
3
Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.甲状腺乳头状癌中央区淋巴结转移的危险因素:一项回顾性研究。
Front Endocrinol (Lausanne). 2023 Nov 17;14:1288527. doi: 10.3389/fendo.2023.1288527. eCollection 2023.
4
Evaluation of Etiology, Clinical Manifestations, Diagnosis, Follow-up, Histopathology and Prognosis Factors in Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis.甲状腺微小乳头状癌的病因、临床表现、诊断、随访、组织病理学及预后因素评估:一项系统评价与Meta分析
Iran J Pathol. 2023;18(4):380-391. doi: 10.30699/IJP.2023.2005196.3134. Epub 2023 Oct 15.
5
Comparison of prophylactic ipsilateral and bilateral central lymph node dissection in papillary thyroid carcinoma: a meta-analysis.比较甲状腺乳头状癌预防性同侧和双侧中央区淋巴结清扫术的效果:一项荟萃分析。
Braz J Otorhinolaryngol. 2023 Nov-Dec;89(6):101318. doi: 10.1016/j.bjorl.2023.101318. Epub 2023 Sep 4.
6
Analysis of the influence factors of cervical lymph node metastasis in Papillary thyroid carcinoma: A retrospective observational study.甲状腺乳头状癌颈淋巴结转移影响因素分析:一项回顾性观察研究。
Medicine (Baltimore). 2023 Sep 8;102(36):e35045. doi: 10.1097/MD.0000000000035045.
7
Hashimoto's thyroiditis is negatively associated with lymph node metastasis in PTMC.桥本甲状腺炎与甲状腺微小癌的淋巴结转移呈负相关。
J Cancer Res Clin Oncol. 2023 Nov;149(17):15525-15533. doi: 10.1007/s00432-023-05332-7. Epub 2023 Aug 30.
8
Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring.循环肿瘤细胞和循环肿瘤 DNA 在乳腺癌诊断和监测中的应用。
Oncol Res. 2023 Jul 21;31(5):667-675. doi: 10.32604/or.2023.028406. eCollection 2023.
9
Predictive nomogram for central lymph node metastasis in papillary thyroid microcarcinoma based on pathological and ultrasound features.基于病理和超声特征的甲状腺微小乳头状癌中央区淋巴结转移预测列线图。
Front Endocrinol (Lausanne). 2023 Jul 6;14:1108125. doi: 10.3389/fendo.2023.1108125. eCollection 2023.
10
Overview and countermeasures of cancer burden in China.中国癌症负担概述及对策。
Sci China Life Sci. 2023 Nov;66(11):2515-2526. doi: 10.1007/s11427-022-2240-6. Epub 2023 Apr 13.

术前循环肿瘤细胞高水平是最大病灶直径≤1.0 cm的乳头状甲状腺癌中央淋巴结转移的独立危险因素。

Preoperative High Level of Circulating Tumor Cells is an Independent Risk Factor for Central Lymph Node Metastasis in Papillary Thyroid Carcinoma with Maximum Lesion Diameter ≤1.0 cm.

作者信息

Yu Ming, Deng Jiaqin, Gu Yihua, Lai Yeqian

机构信息

Department of Thyroid Surgery, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China.

出版信息

Int J Gen Med. 2024 Oct 25;17:4907-4916. doi: 10.2147/IJGM.S487992. eCollection 2024.

DOI:10.2147/IJGM.S487992
PMID:39473633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11520918/
Abstract

OBJECTIVE

Circulating tumor cell (CTC) has been used to assist in the diagnosis and progression assessment of solid tumors, but the relationship between preoperative CTCs levels and central lymph node metastasis (CLNM) of papillary thyroid carcinoma (PTC) needs to be clarified.

METHODS

Data on clinical features (age, gender, Hashimoto's thyroiditis, multifocal, maximum lesion diameter, invaded capsule, clinical stage, and status of lymph node metastasis) of PTC patients treated at our hospital between June 2021 and April 2023 were retrospectively collected. The relationship between the CTCs level and these clinical features was analyzed, especially the relationship between the CTCs level and CLNM.

RESULTS

A total of 705 PTC patients were included, and there were 333 (47.2%) patients with CLNM. Patients with a high CTCs level had higher proportions of multifocality, maximum lesion diameter >1cm, and CLNM than those in patients with a low CTCs level. Tumor size was connected to CTCs level, patients with a high CTCs level had a higher proportion of CLNM than those with a low CTCs level in PTC with maximum lesion diameter ≤1cm (45.3% vs 29.7%) (=0.001). Logistic regression analysis showed that age <55 years old (odds ratio (OR): 2.612, 95% confidence interval (CI): 1.565-4.361, <0.001), invaded capsule (OR: 1.662, 95% CI: 1.098-2.517, =0.016), and high CTCs level (≥8.7 FU/3mL, OR: 2.141, 95% CI: 1.431-3.203, <0.001) were associated with CLNM in PTC with maximum lesion diameter ≤1cm.

CONCLUSION

In PTC patients with maximum lesion diameter ≤1cm, patients with high preoperative CTCs level (≥ 8.7FU/3mL), age <55 years old, and capsular invasion were prone to CLNM. However, similar results were not observed in patients with maximum lesion diameter >1cm.

摘要

目的

循环肿瘤细胞(CTC)已被用于辅助实体瘤的诊断和病情进展评估,但甲状腺乳头状癌(PTC)术前CTC水平与中央区淋巴结转移(CLNM)之间的关系尚需阐明。

方法

回顾性收集2021年6月至2023年4月在我院接受治疗的PTC患者的临床特征(年龄、性别、桥本甲状腺炎、多灶性、最大病灶直径、包膜侵犯、临床分期及淋巴结转移情况)数据。分析CTC水平与这些临床特征之间的关系,尤其是CTC水平与CLNM之间的关系。

结果

共纳入705例PTC患者,其中333例(47.2%)发生CLNM。CTC水平高的患者多灶性、最大病灶直径>1cm及CLNM的比例高于CTC水平低的患者。肿瘤大小与CTC水平相关,在最大病灶直径≤1cm的PTC中,CTC水平高的患者CLNM比例高于CTC水平低的患者(45.3%对29.7%)(P=0.001)。Logistic回归分析显示,年龄<55岁(比值比(OR):2.612,95%置信区间(CI):1.565 - 4.361,P<0.001)、包膜侵犯(OR:1.662,95%CI:1.098 - 2.517,P=0.016)以及高CTC水平(≥8.7 FU/3mL,OR:2.141,95%CI:1.431 - 3.203,P<0.001)与最大病灶直径≤1cm的PTC发生CLNM相关。

结论

在最大病灶直径≤1cm的PTC患者中,术前CTC水平高(≥8.7FU/3mL)、年龄<55岁及包膜侵犯的患者易发生CLNM。然而,在最大病灶直径>1cm的患者中未观察到类似结果。